Advertisement
Screener

NASDAQ:HALO | Increase (Decrease) in Deferred Charges | HALOZYME THERAPEUTICS, INC.

2.7 / 5 stars · 64/120 Roast Me

HALOZYME THERAPEUTICS, INC. Increase (Decrease) in Deferred Charges

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2013-05-08

  • HALOZYME THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2013-03-31 was $42.94K, a 12.60% decline year-over-year.
  • HALOZYME THERAPEUTICS, INC. increase (decrease) in deferred charges for the quarter ending 2012-03-31 was $49.13K.
Period endIncrease (Decrease) in Deferred Charges 3 month
2013-03-31$42.94K
10-Q · filed 2013-05-08
2012-03-31$49.13K
10-Q · filed 2013-05-08